LOTUS EYE HOSPITAL AND INSTITUTE
|
LOTUS EYE HOSPITAL AND INSTITUTE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.36 | 1.40 | 1.96 | 1.44 | 0.75 |
| CEPS(Rs) | 1.80 | 3.19 | 3.39 | 2.64 | 1.87 |
| DPS(Rs) | - | 0.50 | 0.50 | 0.50 | 0.50 |
| Book NAV/Share(Rs) | 28.85 | 28.57 | 27.69 | 26.26 | 25.34 |
| Tax Rate(%) | 46.53 | 27.39 | 27.86 | 27.09 | 21.29 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 7.18 | 13.76 | 16.35 | 15.25 | 11.23 |
| EBIT Margin(%) | 3.76 | 8.74 | 12.45 | 11.07 | 6.58 |
| Pre Tax Margin(%) | 2.79 | 8.33 | 12.01 | 10.52 | 6.15 |
| PAT Margin (%) | 1.49 | 6.05 | 8.67 | 7.67 | 4.84 |
| Cash Profit Margin (%) | 7.56 | 13.78 | 15.00 | 14.10 | 12.04 |
| Performance Ratios | |||||
| ROA(%) | 1.09 | 4.51 | 6.58 | 4.99 | 2.71 |
| ROE(%) | 1.24 | 4.98 | 7.27 | 5.56 | 3.02 |
| ROCE(%) | 3.10 | 7.19 | 10.43 | 8.00 | 4.07 |
| Asset Turnover(x) | 0.73 | 0.75 | 0.76 | 0.65 | 0.56 |
| Sales/Fixed Asset(x) | 0.49 | 0.51 | 0.53 | 0.46 | 0.40 |
| Working Capital/Sales(x) | 11.96 | 6.28 | 4.94 | 5.47 | 4.16 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.04 | 1.95 | 1.89 | 2.17 | 2.52 |
| Receivable days | 9.50 | 9.20 | 6.97 | 6.40 | 7.90 |
| Inventory Days | 25.93 | 22.72 | 19.77 | 19.16 | 21.95 |
| Payable days | 80.52 | 78.70 | 81.76 | 96.13 | 106.98 |
| Valuation Parameters | |||||
| PER(x) | 196.62 | 40.31 | 29.62 | 37.18 | 55.57 |
| PCE(x) | 38.80 | 17.69 | 17.11 | 20.23 | 22.35 |
| Price/Book(x) | 2.42 | 1.98 | 2.10 | 2.03 | 1.65 |
| Yield(%) | - | 0.88 | 0.86 | 0.94 | 1.19 |
| EV/Net Sales(x) | 2.86 | 2.30 | 2.39 | 2.63 | 2.39 |
| EV/Core EBITDA(x) | 29.18 | 13.95 | 12.71 | 14.99 | 17.70 |
| EV/EBIT(x) | 76.12 | 26.26 | 19.19 | 23.73 | 36.39 |
| EV/CE(x) | 2.34 | 1.86 | 1.95 | 1.67 | 1.33 |
| M Cap / Sales | 2.93 | 2.44 | 2.57 | 2.85 | 2.69 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.81 | 2.48 | 20.90 | 20.21 | -20.18 |
| Core EBITDA Growth(%) | -38.76 | -10.21 | 29.62 | 55.74 | -10.31 |
| EBIT Growth(%) | -55.79 | -28.03 | 35.94 | 102.31 | 25.78 |
| PAT Growth(%) | -74.63 | -28.52 | 36.63 | 90.33 | 47.29 |
| EPS Growth(%) | -74.63 | -28.52 | 36.62 | 90.33 | 47.29 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.01 | - | - | - | 0.01 |
| Current Ratio(x) | 1.56 | 2.21 | 2.83 | 2.24 | 2.34 |
| Quick Ratio(x) | 1.04 | 1.70 | 2.30 | 1.83 | 2.03 |
| Interest Cover(x) | 3.88 | 20.98 | 28.69 | 20.09 | 15.52 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of LOTUS EYE HOSPITAL AND INSTITUTE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LOTUS EYE HOSPITAL AND INSTITUTE | ₹278.9 Cr | 10% | 12.2% | 110.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹100,073.0 Cr | 2.3% | -0.4% | 0.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹93,121.1 Cr | -3.5% | -8.1% | -9.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹64,296.0 Cr | 1% | -3.1% | 36.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,127.9 Cr | 1.1% | -3.4% | 33.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹28,358.7 Cr | 2.4% | -8.5% | -1.2% | Stock Analytics | |
LOTUS EYE HOSPITAL AND INSTITUTE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LOTUS EYE HOSPITAL AND INSTITUTE | 10% |
12.2% |
110.6% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses
